- Home
- FULC vs TLS Comparison
FULC vs TLS Comparison
Compare FULC & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- TLS
- Stock Information
- Founded
- FULC 2015
- TLS 1969
- Country
- FULC United States
- TLS United States
- Employees
- FULC N/A
- TLS N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- TLS EDP Services
- Sector
- FULC Health Care
- TLS Technology
- Exchange
- FULC Nasdaq
- TLS Nasdaq
- Market Cap
- FULC 210.9M
- TLS 198.1M
- IPO Year
- FULC 2019
- TLS 2020
- Fundamental
- Price
- FULC $2.90
- TLS $2.39
- Analyst Decision
- FULC Hold
- TLS Buy
- Analyst Count
- FULC 8
- TLS 6
- Target Price
- FULC $6.57
- TLS $4.13
- AVG Volume (30 Days)
- FULC 427.9K
- TLS 350.6K
- Earning Date
- FULC 05-12-2025
- TLS 03-10-2025
- Dividend Yield
- FULC N/A
- TLS N/A
- EPS Growth
- FULC N/A
- TLS N/A
- EPS
- FULC N/A
- TLS N/A
- Revenue
- FULC $80,000,000.00
- TLS $108,272,000.00
- Revenue This Year
- FULC N/A
- TLS $38.54
- Revenue Next Year
- FULC N/A
- TLS $36.17
- P/E Ratio
- FULC N/A
- TLS N/A
- Revenue Growth
- FULC 2752.05
- TLS N/A
- 52 Week Low
- FULC $2.78
- TLS $1.89
- 52 Week High
- FULC $10.13
- TLS $5.03
- Technical
- Relative Strength Index (RSI)
- FULC 37.74
- TLS 28.52
- Support Level
- FULC $3.00
- TLS $2.62
- Resistance Level
- FULC $3.35
- TLS $2.84
- Average True Range (ATR)
- FULC 0.18
- TLS 0.13
- MACD
- FULC 0.02
- TLS -0.01
- Stochastic Oscillator
- FULC 24.78
- TLS 9.62
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.